In addition to pathological changes, the FLV complexes also induce rapid hemopoietic changes, notably in the progenitor cells in the erythroid pathways. The most dramatic change is the increase in colony-forming unit-erythroids (CFU-E*) 2 (17) (18) (19) . In addition, differences in the nature and frequencies of erythroid progenitor cells can also be detected in mice infected with the two strains of FLV. For example, whereas the proliferation and differentiation of CFU-E* in FV-A-infected mice are still under the control of erythropoietin (epo) (19, 20) , erythropoiesis and development of CFU-E* in FV-P-infected mice are independent of epo (17-19, 21, 22) . These rapid erythropoietic modulations are functions of the SFFV components (19) , and little change can be detected when the helper virus F-MuLV alone is injected into adult susceptible mice.
Several reports (20, (23) (24) (25) , however, indicate that when newborn BALB/c or NIH Swiss mice are used, the replication-independent F-MuLV, which has often been considered's simply the helper virus, can also induce splenomegaly. In this study, we examinedthe modulation of erythropoiesis by the replication-independent F-MuLV in newborn and adult mice.
Materials and Methods
Virus. An NB-tropic Friend F-MuLV was cloned from a FV-P complex by limiting dilution (14) . This virus has been shown repeatedly over the last 5 yr (14, 19, 20, 26) by both biochemical and biological methods to contain no detectable SFFV. Titer of the F-MuLV was determined by the XC plaque assay (27) .
Mice. BALB/c and DBA/2 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Newborn BALB/c mice were obtained from the Ontario Cancer Institute Animal Colony.
Culture of Progenitor Cell Colonies
CFU-E AND ERYTHROID BURST (BFU-E) ASSAY. CFU-E and BFU-E progenitor colony assays were performed as described previously (19, 28) . In brief, bone marrow cells were obtained by flushing femurs with a-medium. Spleen cell suspensions were made by pressing spleen fragments with glass slides. After washing with a-medium, the bone marrow or spleen cells were plated in 1 ml of 0.8% methylcellulose in a-medium or Iscove's modified Dulbecco's medium supplemented with 7.5 × l0 -5 M 2-mercaptoethanol, 1% deionized bovine serum albumin, and 30% fetal calf serum (Flow Laboratories, Inc., Rockville, MD). Erythropoietin (step III, lot 3038; Connaught Laboratory) was added at a final concentration of 0.2-2.0 U/ml for CFU-E or for BFU-E colony assays. Colonies containing 8-64 hemoglobinized cells at day 2 were counted as CFU-E or CFU-E*, and clusters of three or more colonies were counted as BFU-E or BFU-E* at day 7.
Results
To examine changes in the hemopoietic progenitor cells, 1-d-old BALB/c mice were infected with 3 × 105 XC plaque U of F-MuLV. 7 wk after infection, the spleens and marrow cells were obtained from these infected mice and the frequencies of CFU-E* and BFU-E* were measured. These results were compared with those obtained from uninfected BALB/c mice. Results in Table I indicate that whereas the levels of CFU-E and BFU-E in the spleens and marrows of the uninfected mice are consistent with those reported previously for normal mice, changes in the erythroid bursts colonies can be detected in the spleens and marrows of the mice infected by F-MuLV.
Unlike mice infected with the FLV complexes, BALB/c mice infected by F-MuLV Spleen and marrow cells were obtained from normal 7-wk-old BALB/c mice or 7-wk-otd BALB/c mice infected with 3 X l0 s XC plaque U of F-MuLV at the time of birth. The cells were washed and plated for CFU-E or CFU-E* and BFU-E or BFU-E* as described in Materials and Methods. CFU-E* and BFU-E* denote CFU-E and BFU-E-like colonies in the virally infected animals. Data are expressed as number of colonies per 105 nucleated cells. At least four plates were used in each determination.
as newborns did not have dramatic increase in the level of either epo-dependent or -independent CFU-E* in the spleen or marrow (possibly even a slight decrease). Instead, there was a dramatic increase in the levels of BFU-E-like colonies. This level, which reached ~ 1,500 bursts/105 cells or ~5 × 10 v BFU-E*/spleen was much higher than those reported (29) for mice infected with the FLV complexes (T. Shibuya and T. W. Mak, unpublished observations). A similar picture was seen in the bone marrow of F-MuLV-infected mice, with ~300 BFU-E*/105 cells or 3 × 105 cells/femur. These F-MuLV-induced BFU-E* colonies were similar in size and morphology to the BFU-E colonies in uninfected animals ( Fig. 1) . However, they differ from the normal BFU-E in that they contained less hemoglobinized cells per colony. To demonstrate that these BFU-E* were erythroid in nature, 20 colonies were picked and stained for spectrin-positive cells by immunofluorescence as described previously (24) . Results showed that >99% of the cells contained the erythroid-specific marker spectrin, confirming the erythroid nature of these BFU-E*. Although a high level of erythroid bursts (200-300 BFU-E*/105 cells) were observed, the number of CFU-E*/105 cells in the marrow and spleens was unchanged or slightly reduced. The formation of these erythropoietic progenitor cells was dependent on epo, as no erythroid colonies or erythroid bursts could be detected in the absence of the hormone.
Epo Requirement in the Erythroid Progenitor Colonies (CFU-E and BFU-E) in F-MuL Vinfected Mice.
The level of epo required for the formation of erythroid progenitor colonies BFU-E* and CFU-E* in mice infected with F-MuLV was also examined. Cells from the marrow and spleens of infected animals were obtained at 7 wk after infection, and the levels of CFU-E* and BFU-E* were determined in the absence of any added epo and in the presence of varying amounts of added epo. The results of such experiments are illustrated in Figs. 2 and 3. As in the results described above, the spleen cells contained a high level of erythroid bursts and their formation was dependent on added epo. The data in Fig. 2 show that the number of BFU-E* increased with added epo and reached a plateau of ~ 1,200-1,500 BFU-E*/105 spleen cells at 0.2 U of epo/plate and ~500 BFU-E*/105 marrow cells at ~1.0 U/plate of the hormone. The epo dose-response curves for the formation of the CFU-E* in the marrow cells increased to a plateau of ~250 CFU-E*/105 cells at ~0.5 U of epo/ plate. For comparison purposes, dose-resonse curves for BFU-E and CFU-E in normal uninfected BALB/c mouse marrow are also summarized in Fig. 4 .
Modulation of E~ythropoiesis in Adult Mice by F-MuL V and Phenylhydrazine (PHZ).
Results described above and elsewhere (13, 20, 30) indicate that injection of F-MuLV alone into adult mice results in little or no erythropoietic changes or splenomegaly. Modulation of the erythropoietic changes in adult mice, however, can be induced by the addition of certain chemicals like PHZ. Furthermore, Tambourin et al. (31) have shown that administering the polycythemia FLV complex in conjunction with PHZ resulted in an accelerated disease. In a study similar to those described by S. Ruscetti and E. Scolnick (unpublished observation), we have examined FtG. 3. Epo dose-response curves for CFU-E* in BALB/c mice infected at birth with F-MuLV. Spleen cells (0) and marrow cells (0) were obtained as described in Fig. 2 , and CFU-E* were measured at 0, 0.2, 0.5, 1.0, and 2.0 U of epo/plate. In this experiment, Iscove's modified Dulbecco's medium was used. FIe. 4. Epo dose-response curves for BFU-E and CFU-E in uninfected BALB/c mice. BALB/c mice at 7 wk old were killed, and the bone marrow cells were plated for BFU-E (upper panel) or CFU-E (lower panel) in the presence of either Iscove's modified Dulbecco's medium (C)) or a-medium (0) as described in Materials and Methods.
whether F-MuLV can affect the erythropoiesis changes in adult mice treated with PHZ.
To this end, adult mice (8 wk old) were injected with one of the following: (a) 1. At various times after the administration of these viruses and PHZ, the spleen weights, hematocrits, and number of CFU-E in the spleens of of these mice were measured. Results of these experiments are summarized in Fig. 5 . As can be seen in Fig. 5 (upper panel) , only a sight increase in spleen weights could be detected in these adult mice infected with F-MuLV alone. With the administration of PHZ there was a moderate increase in spleen weights from ~0.1 to -0.3 g/spleen. This slight splenomegaly was maintained until the administration of PHZ ceased at 4 wk. When tration of PHZ ceased. With the administration of PHZ and FV-P, the hematocrit values dropped after 1 wk, but reversed and rose to a level of ~65% by 3 wk. The levels of erythroid progenitor cells in these adult mice under the different treatments were also monitored. The number of CFU-E* in the spleens of these mice was measured before infection and at 1 and 3 wk after initiation of infection. Results in Fig. 6 , upper and lower panels, indicate that with the injection of F-MuLV there was a moderate increase in the number of CFU-E*. All the CFU-E* were epo dependent. With the administration of PHZ, the level of CFU-E* increased to ~3,000/10 ~ spleen ceils or 107 per spleen 3 wk later. The majority of these erythroid progenitor cells were also dependent on the addition of epo. The level of CFU-E*, however, increased further when F-MuLV and PHZ were administered. These erythroid colonies, which were also epodependent, increased to ~4,500/105 cells or ~4 × 107 CFU-E*/spleen. When FV-P and PHZ were injected, there was a dramatic increase in the levels of CFUoE* in the spleens. These CFU-E* were, however, independent of epo. Experiments similar to those described here with F-MuLV and PHZ were also performed in adult (8 wk old) DBA/2 mice. Results indicated that like those in BALB/c mice, the injection of F-MuLV into PHZ treated mice also induced splenomegaly, a decrease in hematocrits, and enhancement of levels of CFU-E*.
Discussion
The present study confirms and extends earlier findings (20, (23) (24) (25) ) that F-MuLV, which is often presumed not to play an important role in Friend disease, can induce erythropoietic changes in newborn BALB/c mice. In addition, it was shown that if the hemopoietic component was perturbed by PHZ, F-MuLV can also modulate erythropoiesis in adult mice. The erythropoietic pertubations by F-MuLV in newborn mice, however, are different from those described before for the infection by the FLV complexes. It was reported that subsequent to infection by FLV complexes, a dramatic increase (up to 5,000-fold/spleen) in CFU-E* was observed (17) (18) (19) (20) (21) (22) . In addition, it was determined that the nature of these CFU-E* in the FV-A-or FV-P-infected spleens was different. Whereas the proliferation and differentiation of CFU-E* in FV-A-infected mice are still under the control of epo (19, 20) , erythropoiesis and development of CFU-E* in FV-P-infected mice are independent of the hormone (17-19, 21, 22) . It was reported that changes in the erythroid bursts can also be detected in response of FLV infection both in vivo (29) and in vitro (32, 33) . However, as noted in these mice infected in vivo by the FLV, the enhancement of the erythroid bursts was insignificant when compared with the dramatic increase in CFU-E*. Although the CFU-E* increase in the FLV-infected spleens can be as much as 5,000 times/spleen, the elevation in BFU-E* in the infected spleens was only ~20-30-fold/ spleen (28, 29) . This increase in BFU-E* could be partially accounted for by the dramatic increase in spleen weights of these mice.
In the present study, we have shown that subsequent to F-MuLV infection in newborn BALB/c mice, a very different picture was observed. Instead of the increase in CFU-E* observed in FLV-infected mice, a dramatic elevation in the number of BFU-E* was observed in the spleens and marrows of mice infected by F-MuLV as newborns. This increase of BFU-E* in the spleens can reach a level of ~3,000 times that of the normal BFU-E in uninfected spleens. The number of CFU-E* however, did not increase in these F-MuLV-infected mice. This finding suggests that the epodependent erythroid colonies observed earlier (20) were BFU-E* and not CFU-E*. It is possible that because the erythroid colonies in the earlier report (20) were evaluated only on day two, the colonies scored were those destined to be BFU-E*.
Although these F-MuLV BFU-E* resemble the normal bursts, it is not clear how similar they are to the normal day 7 BFU-E reported by Axelrad et al. (34) or to the erythroid bursts induced by FLV complexes in vivo (29) and in vitro (32, 33) . At least one minor difference from the normal BFU-E can be detected. When compared with the normal BFU-E under the experimental conditions described here, these F-MuLVinduced BFU-E* colonies contained less hemoglobinized cells.
At this time it is not clear why F-MuLV can induce these erythropoietic changes in newborn BALB/c mice but not in adults. Ruscetti et al. (35) have recently suggested that the ability to induce these erythropoietic changes may be related to the release of a virus, termed mink cell focus-forming virus. Another reason may be related to the nature of the hemopoietic compartment of the newborn mice, which is known to be more active, and different from that of adult mice (36) . The possibility that a more active hemopoietic compartment may be more susceptible to infection and modulation by F-MuLV is also supported by our findings. We have shown that if the hemopoietic compartment of adult mice is perturbed by treatment with PHZ, splenomegaly can be induced by infection with F-MuLV. This finding was first observed by S. Ruscetti, T. Feild, L. Davis, and A. Oliff (unpublished observations). In the present study we have confirmed this finding and extended it to other erythropoietic changes, including the induction of anemia and the enhancement of CFU-E*. It is possible that after treatment with PHZ, a chemical known to induce anemia (31), the hemopoietic tissues will regenerate and the immature hemopoietic cells, including the erythroid precursor cells, will cycle more actively. This cycling of the erythroid precursor cells may render the mouse more susceptible to infection by F-MuLV. The hypothesis that cycling of cells may be important for infection and transformation has previously been proposed, first by Humphries and Temin (38) and more recently by Suzuki and Axelrad (36) and Oliff et al. (38) .
On the basis of data reported previously (20, (23) (24) (25) and this communication, it is not possible to determine the target cell(s) for infection or transformation by F-MuLV, nor is it possible to determine the relative stage of differentiation of these F-MuLV-transformed cells with respect to those induced by the FV-A or FV-P complexes. Based on the finding herein that a dramatic enhancement of BFU-E* was observed in these F-MuLV-infected spleens with no increase in the levels of the more mature CFU-E*, as in the case of the FV-A-and FV-P-infected mice (17) (18) (19) (20) , it is tempting to postulate that the F-MuLV-transformed cells are less differentiated than those from the FV-A-or FV-P-infected spleens. Support of this hypothesis can also be found in the study of the recently established Friend erythroleukemic cell (FLC) lines from the F-MuLV-infected spleens (24, 38) . It was determined that whereas FLC lines established from FV-P-infected spleens contain a high level of spectrin-and a low level of benzidine-positive cells (39) , FLC lines from F-MuLV-infected newborn mice contain only spectrin-positive cells, but no benzidine-positive cells (24) . Furthermore, it was found that although FLC lines established from FV-A and FV-P infected spleens respond to epo or dimethylsulphoxide (DMSO) to differentiate along the erythroid pathway (39), FLC lines from F-MuLV-infected mice will not respond to induction by DMSO (24, 40) epo (24) , or other commonly used inducers (38) . The finding that a dramatic elevation of BFU-E* with no increase in CFU-E* also suggests that the leukemic block induced by F-MuLV infection may be between that of the BFU-E and CFU-E. Furthermore, these data would suggest that the target cell(s) may be at the level of BFU-E or earlier. Alternatively, F-MuLV may infect and/or transform cells that in turn release or induce factors that can affect a more immature erythroid subpopulation(s).
Summary
Friend leukemia virus (FLV) is a complex of two viruses, a defective spleen focusforming component (SFFV) and a helper-independent virus, F-MuLV. Although the effects of the erythropoietic changes in susceptible adult mice after infection of FLV have been attributed to the SFFV component, it has been shown that the F-MuLV alone can induce certain erythropoietic changes in susceptible newborn mice. In the present study, we have shown that very different erythropoietic changes were observed after infection with F-MuLV. Unlike the FLV complexes, the F-MuLV did not induce in newborn BALB/c mice an increase in the erythroid progenitor cells (CFU-E*). Instead, a dramatic increase in the bursts (BFU-E*) can be detected in the infected spleens and marrows. The frequency of BFU-E* in the infected spleens increased to a level of ~ 1,500/105 cells or 5 × 10V/spleen. In the marrows, frequency increased to a level of 300 BFU-E*/105 cells or ~3 X 10S/femur. These F-MuLVinduced bursts, BFU-E*, differ from the BFU-E in uninfected mice. For example, although the morphology of the erythroid bursts in the F-MuLV infected mice was similar to that in the uninfected mice, the colonies were less hemoglobinized when compared with those in the uninfected mice.
We have also shown that if adult BALB/c or DBA/2 mice were administered phenylhydrazine (PHZ), infection of cloned F-MuLV can induce certain erythropoietic changes. For example, although F-MuLV alone has little effect on the spleen weights (0.1-0.15 g) of adult mice and PHZ can only moderately increase the spleen weights (0.3 g), infection of F-MuLV in PHZ-treated mice can induce a severe splenomegaly (-1 g) . Similarly, the infection of F-MuLV in PHZ-treated mice can also induce a severe anemia and an increase in the frequency of CFU-E*.
These results indicate that F-MuLV, without the SFFV components, can modulate erythropoesis in newborn and adult mice. The finding that F-MuLV in newborn BALB/c mice elicit very different erythropoietic changes also has interesting implications. The induction of a dramatic increase in BFU-E* with no increase (possibly even a slight decrease) in CFU-E* implies that the leukemic block in F-MuLVinfected newborn mice is at a stage between BFU-E and CFU-E. The data also suggest that F-MuLV infect different, possibly more immature, erythroid target cells than the FLV complexes.
